Uncategorized

Allegro Ophthalmics to Present Clinical Research on the Company’s Novel Integrin-Regulating Portfolio at the American Academy of Ophthalmology Annual Meeting

by Business Wire • 2019/10/08 • 0 Comments

SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)-- #AAO2019--Allegro Ophthalmics to present clinical research on its novel integrin-regulating portfolio at the American Academy of Ophthalmology annual meeting.

Full Story →

← New Data Insights from the Phase 3 Teprotumumab Trial (OPTIC) to be Presented at the American Society of Ophthalmic Plastic and Reconstructive Surgery (ASOPRS) Scientific Symposium

Electrified Graphene Filters Kill All Pathogens and Their Byproducts →

Post navigation